Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Migraine Disorders: HELP
Melissa Grozinski-Wolff
Based on 2 articles published since 2009
(Why 2 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 2 published articles on Migraine Disorders from 2009 through 2019, it is not possible for Expertscape to reliably rate Melissa Grozinski-Wolff's expertise on this topic.

Work Locations
Details
Most likely:    Teva Pharmaceutical Industries      
2018
  • Mayo Clinic Arizona, Phoenix. · Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Teva Pharmaceuticals, Frazer, Pennsylvania. · NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, England. · Pubmed 29800211
2017
  • From the Jefferson Headache Center, Thomas Jefferson University, Philadelphia (S.D.S.), and Teva Pharmaceuticals, Frazer (M.E.B., P.P.Y., T.B., M.G.-W., R.Y., Y.M., E.A.) - both in Pennsylvania · Mayo Clinic Arizona, Phoenix (D.W.D.) · and National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College London, London (P.J.G.). · Pubmed 29171818
Probable:    Thomas Jefferson University   Contact    
2017
  • From the Jefferson Headache Center, Thomas Jefferson University, Philadelphia (S.D.S.), and Teva Pharmaceuticals, Frazer (M.E.B., P.P.Y., T.B., M.G.-W., R.Y., Y.M., E.A.) - both in Pennsylvania · Mayo Clinic Arizona, Phoenix (D.W.D.) · and National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College London, London (P.J.G.). · Pubmed 29171818
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Melissa Grozinski-Wolff in 2009-2019 about Migraine Disorders:

  • Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. 2018
  • Fremanezumab for the Preventive Treatment of Chronic Migraine. 2017
Show List of Full Article Records
Google Searches

Learn more about Melissa Grozinski-Wolff using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Teva Pharmaceutical Industries
Thomas Jefferson University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Teva Pharmaceutical Industries
2018
  • Mayo Clinic Arizona, Phoenix. · Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Teva Pharmaceuticals, Frazer, Pennsylvania. · NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, England. · Pubmed 29800211
2017
  • From the Jefferson Headache Center, Thomas Jefferson University, Philadelphia (S.D.S.), and Teva Pharmaceuticals, Frazer (M.E.B., P.P.Y., T.B., M.G.-W., R.Y., Y.M., E.A.) - both in Pennsylvania · Mayo Clinic Arizona, Phoenix (D.W.D.) · and National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College London, London (P.J.G.). · Pubmed 29171818
Thomas Jefferson University
2017
  • From the Jefferson Headache Center, Thomas Jefferson University, Philadelphia (S.D.S.), and Teva Pharmaceuticals, Frazer (M.E.B., P.P.Y., T.B., M.G.-W., R.Y., Y.M., E.A.) - both in Pennsylvania · Mayo Clinic Arizona, Phoenix (D.W.D.) · and National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College London, London (P.J.G.). · Pubmed 29171818
Yearly article counts 01100000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.